Pharvaris N.V.

NASDAQ: PHVS · Real-Time Price · USD
22.30
-0.69 (-3.00%)
At close: Aug 15, 2025, 3:45 PM

Pharvaris Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 252.27K 150.19K 80.46K
Gross Profit
n/a -252.27K -150.19K -80.46K
Operating Income
-145.69M -96.91M -86.74M -65.9M
Interest Income
n/a n/a 16.11 267.51
Pretax Income
-132.4M -99.83M -75.65M -42.66M
Net Income
-134.22M -100.88M -76.33M -42.73M
Selling & General & Admin
47.13M 31.34M 29.34M 18.35M
Research & Development
98.56M 65.58M 57.38M 35.79M
Other Expenses
n/a -0.00 n/a n/a
Operating Expenses
145.69M 96.91M 86.71M 54.14M
Interest Expense
n/a n/a 16.11K 278.18K
Selling & Marketing Expenses
400K 200K n/a n/a
Cost & Expenses
145.69M 96.91M 86.71M 54.14M
Income Tax Expense
1.82M 1.05M 679.09K 70.12K
Shares Outstanding (Basic)
54.02M 38.39M 33.59M 30.41M
Shares Outstanding (Diluted)
54.02M 38.39M 33.59M 30.41M
EPS (Basic)
-2.48 -2.63 -2.27 -1.41
EPS (Diluted)
-2.48 -2.63 -2.27 -1.41
EBITDA
-145.59M -96.85M -86.58M -54.06M
EBIT
-145.69M -96.91M -86.71M -54.14M
Depreciation & Amortization
95K 59.78K 150.19K 80.46K